Total Payments
$4,342
2024 Payments
$2,070
Companies
31
Transactions
178
Medicare Patients
649
Medicare Billing
$58,999
Payment Breakdown by Category
Food & Beverage$4,342 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,342 | 178 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $779.10 | 45 | $0 (2024) |
| Amgen Inc. | $575.49 | 12 | $0 (2024) |
| Lilly USA, LLC | $332.50 | 17 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $286.80 | 15 | $0 (2024) |
| Corcept Therapeutics | $232.32 | 5 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $226.26 | 2 | $0 (2019) |
| Abbott Laboratories | $214.44 | 13 | $0 (2024) |
| Horizon Therapeutics plc | $184.35 | 3 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $163.57 | 8 | $0 (2023) |
| Medtronic, Inc. | $158.18 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,070 | 96 | Novo Nordisk Inc ($519.25) |
| 2023 | $556.10 | 25 | Novo Nordisk Inc ($195.73) |
| 2022 | $674.24 | 30 | Amgen Inc. ($163.36) |
| 2021 | $442.20 | 15 | AstraZeneca Pharmaceuticals LP ($100.41) |
| 2020 | $174.42 | 6 | Amgen Inc. ($94.68) |
| 2019 | $320.48 | 4 | Janssen Pharmaceuticals, Inc ($226.26) |
| 2017 | $105.03 | 2 | PFIZER INC. ($59.54) |
All Payment Transactions
178 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Diabetes | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $28.92 | General |
| Category: Diabetes | ||||||
| 11/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Bone Health | ||||||
| 11/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $5.12 | General |
| Category: Diabetes Care | ||||||
| 11/20/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $7.77 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $23.33 | General |
| Category: Endocrinology | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 11/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Diabetes Care | ||||||
| 11/06/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $80.89 | General |
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $19.33 | General |
| Category: Insulin Pump | ||||||
| 10/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $28.36 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: Bone Health | ||||||
| 10/14/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $37.34 | General |
| Category: Endocrinology | ||||||
| 10/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Diabetes Care | ||||||
| 10/10/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $21.59 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 219 | 277 | $60,611 | $19,821 |
| 2022 | 11 | 329 | 433 | $91,043 | $26,812 |
| 2021 | 5 | 101 | 131 | $33,718 | $12,366 |
Total Patients
649
Total Services
841
Medicare Billing
$58,999
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 87 | 107 | $23,723 | $7,969 | 33.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 56 | $10,461 | $3,477 | 33.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 29 | $9,557 | $3,322 | 34.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $8,971 | $2,708 | 30.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $4,340 | $1,331 | 30.7% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Facility | 2023 | 13 | 13 | $2,730 | $759.33 | 27.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 15 | 18 | $389.00 | $151.20 | 38.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 11 | 11 | $440.00 | $104.72 | 23.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 106 | 134 | $28,755 | $8,928 | 31.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 55 | 64 | $19,912 | $5,674 | 28.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 29 | 67 | $11,055 | $3,594 | 32.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $10,841 | $2,911 | 26.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 14 | $4,340 | $1,418 | 32.7% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Facility | 2022 | 20 | 20 | $4,200 | $1,092 | 26.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 17 | 37 | $3,293 | $1,027 | 31.2% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 17 | 23 | $2,300 | $580.69 | 25.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 11 | 13 | $1,937 | $562.08 | 29.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 12 | 13 | $2,782 | $520.60 | 18.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 11 | $1,628 | $505.69 | 31.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 28 | 32 | $9,920 | $3,721 | 37.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 32 | 32 | $9,376 | $3,410 | 36.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 12 | 36 | $5,940 | $2,037 | 34.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 11 | 11 | $4,202 | $1,617 | 38.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 20 | $4,280 | $1,581 | 36.9% |
About Dr. Jennifer Turner, MD
Dr. Jennifer Turner, MD is a Internal Medicine healthcare provider based in Morgantown, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2015. The National Provider Identifier (NPI) number assigned to this provider is 1760878623.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jennifer Turner, MD has received a total of $4,342 in payments from pharmaceutical and medical device companies, with $2,070 received in 2024. These payments were reported across 178 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($4,342).
As a Medicare-enrolled provider, Turner has provided services to 649 Medicare beneficiaries, totaling 841 services with total Medicare billing of $58,999. Data is available for 3 years (2021–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism
- Location Morgantown, WV
- Active Since 04/07/2015
- Last Updated 04/08/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1760878623
Products in Payments
- Ozempic (Drug) $385.05
- EVENITY (Biological) $310.45
- Rybelsus (Drug) $291.92
- Korlym (Drug) $232.32
- TEPEZZA (Drug) $184.35
- MOUNJARO (Drug) $154.49
- TRADJENTA (Drug) $154.06
- FREESTYLE LIBRE 3 (Device) $153.43
- GVOKE HYPOPEN (Drug) $125.54
- RECORLEV (Drug) $125.03
- INVOKANA (Drug) $123.23
- Dexcom G6 Transmitter (Medical Supply) $106.77
- XARELTO (Drug) $103.03
- TEPEZZA (Biological) $100.92
- SOLIQUA 100/33 (Biological) $85.48
- Repatha (Biological) $83.23
- Wegovy (Drug) $80.55
- SYNTHROID (Drug) $73.77
- CeQur Simplicity (Device) $72.44
- TRULICITY (Drug) $70.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Morgantown
Dr. Partho Sengupta, Md, Dm, MD, DM
Internal Medicine — Payments: $152,664
Internal Medicine $152,664
Dr. Ashkan Emadi, Md, Phd, MD, PHD
Internal Medicine — Payments: $123,347
Internal Medicine $123,347
Dr. Latoya Linton-Frazier, Md, MD
Internal Medicine — Payments: $72,467
Internal Medicine $72,467
Ward Paine, Md, MD
Internal Medicine — Payments: $69,016
Internal Medicine $69,016
Dr. John Nasr, Md, MD
Internal Medicine — Payments: $35,066
Internal Medicine $35,066
Dr. Matthew Gaskill, D.o, D.O
Internal Medicine — Payments: $21,227
Internal Medicine $21,227